Literature DB >> 7885561

Multifocal inflammatory leukoencephalopathy associated with levamisole and 5-fluorouracil: case report.

T C Chen1, D R Hinton, L Leichman, R D Atkinson, M L Apuzzo, W T Couldwell.   

Abstract

Levamisole and 5-fluorouracil have now become the standard chemotherapeutic regimen for patients with Stage III colon carcinoma. A case of multifocal inflammatory leukoencephalopathy secondary to levamisole alone or combination of levamisole and 5-fluorouracil is reported. Magnetic resonance imaging with gadolinium demonstrated multifocal contrast-enhancing frontal, parietal, occipital, and periventricular white matter lesions. A stereotactic biopsy revealed reactive gliosis and macrophage infiltration, without evidence of metastatic tumor. Despite continuation of 5-fluorouracil, resolution of contrast-enhancing lesions on magnetic resonance imaging without further neurological sequelae occurred when levamisole was stopped. The patient died with evidence of systemic metastasis 6 months later. Autopsy examination of the brain revealed multifocal demyelinating lesions, with no evidence of metastatic tumor. Immunoperoxidase studies of demyelinated lesions demonstrated infiltrating macrophages strongly positive for Class II antigens, interleukin-6, and interleukin-1 alpha. Surrounding astrocytes were positive for granulocyte macrophage colony-stimulating factor. Small numbers of perivascular T cells were present. This patient represents the first autopsy documented case of levamisole associated multifocal inflammatory leukoencephalopathy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7885561     DOI: 10.1227/00006123-199412000-00019

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  4 in total

1.  Adverse reactions with levamisole vary according to its indications and misuse: A systematic pharmacovigilance study.

Authors:  Jérémy T Campillo; Céline Eiden; Michel Boussinesq; Sébastien D S Pion; Jean-Luc Faillie; Cédric B Chesnais
Journal:  Br J Clin Pharmacol       Date:  2021-09-15       Impact factor: 3.716

2.  Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system.

Authors:  Ruolan Han; Yin M Yang; Joerg Dietrich; Anne Luebke; Margot Mayer-Pröschel; Mark Noble
Journal:  J Biol       Date:  2008-04-22

3.  Clinical features and magnetic resonance image analysis of 15 cases of demyelinating leukoencephalopathy induced by levamisole.

Authors:  Ruifang Yan; Qingwu Wu; Jipeng Ren; Hongkai Cui; Kaihua Zhai; Zhansheng Zhai; Qinghong Duan
Journal:  Exp Ther Med       Date:  2013-04-24       Impact factor: 2.447

4.  Targeting Thymidylate Synthase Enhances the Chemosensitivity of Triple-Negative Breast Cancer Towards 5-FU-Based Combinatorial Therapy.

Authors:  Nair Hariprasad Haritha; Akbar Nawab; Vinod Vijayakurup; Nikhil Ponnoor Anto; Vijayasteltar B Liju; Vijai V Alex; Areekkara Nisthul Amrutha; Sreekumar U Aiswarya; Mundanattu Swetha; Balachandran S Vinod; Sankar Sundaram; Maria V Guijarro; Thomas Herlevich; Archana Krishna; Nesteena K Nestory; Smitha V Bava; Chittalakkottu Sadasivan; Maria Zajac-Kaye; Ruby John Anto
Journal:  Front Oncol       Date:  2021-07-15       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.